5 Einträge von 5 mit build market
www.cslbehring.ch
Datum der Indexierung
erkannte Namen Gérard Jenni | Alex Gertsch | Georg Ptak | Bill Mezzanotte | Jérôme Gremaud | Burkhard Statutory | Corona Anderer |
weitere Namen in www.cslbehring.ch 7
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf
Kombination Keywords phase research | with market | transplant clinical | anti global | cidp privigen | products study | breakthrough hizentra | medicines development | specialty haemophilia | patients immunoglobulins |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
build market leading segments • Build on PRIVIGEN ® experience in CIDP • Launch HIZENTRA ® in CIDP • Novel delivery devices • New indications eg IIM, SSc • rFc multimer HIZENTRA ® : Innovator, Market Leader 7 years and 51 countries 90,000 patient-yea market new and existing products; difficulties or delays in manufacturing; trade buying patterns and fluctuations in interest and currency exchange rates; legislation or regulations that affect product production, distribution, pr
Text Inhalt Text aus URL
Log Metriken 446193
erkannte Namen Gérard Jenni | Alex Gertsch | Georg Ptak | Bill Mezzanotte | Jérôme Gremaud | Burkhard Statutory | Corona Anderer |
weitere Namen in www.cslbehring.ch 7
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf
Kombination Keywords phase research | with market | transplant clinical | anti global | cidp privigen | products study | breakthrough hizentra | medicines development | specialty haemophilia | patients immunoglobulins |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
build market leading segments • Build on PRIVIGEN ® experience in CIDP • Launch HIZENTRA ® in CIDP • Novel delivery devices • New indications eg IIM, SSc • rFc multimer HIZENTRA ® : Innovator, Market Leader 7 years and 51 countries 90,000 patient-yea market new and existing products; difficulties or delays in manufacturing; trade buying patterns and fluctuations in interest and currency exchange rates; legislation or regulations that affect product production, distribution, pr
Text Inhalt Text aus URL
Log Metriken 446193
www.cslbehring.ch
Datum der Indexierung 13.03.2021 22:48:29
erkannte Namen Alex Gertsch | Gérard Jenni | Amir Abrashi | Georg Ptak | Jérôme Gremaud | Bill Mezzanotte | Gene Therapy | Nat Rev | Tim Frei | Roman Lareida |
weitere Namen in www.cslbehring.ch 10
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf
Kombination Keywords driven research | promise specialty | with fluad | cidp japan | phase cell | anti market | transplant data | hizentra products | privigen study | clinical patients |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
build market leading segments • Build on PRIVIGEN ® experience in CIDP • Launch HIZENTRA ® in CIDP • Novel delivery devices • New indications e.g. IIM, SSc • rFc multimer | Driven by Our Promise ™ 55 | Driven by Our Promise ™ 55 Proven efficacy and t market new and existing products; difficulties or delays in manufacturing; trade buying patterns and fluctuations in interest and currency exchange rates; legislation or regulations that affect product production, distribution, pr
Text Inhalt Text aus URL
Log Metriken 446174
erkannte Namen Alex Gertsch | Gérard Jenni | Amir Abrashi | Georg Ptak | Jérôme Gremaud | Bill Mezzanotte | Gene Therapy | Nat Rev | Tim Frei | Roman Lareida |
weitere Namen in www.cslbehring.ch 10
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf
Kombination Keywords driven research | promise specialty | with fluad | cidp japan | phase cell | anti market | transplant data | hizentra products | privigen study | clinical patients |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
build market leading segments • Build on PRIVIGEN ® experience in CIDP • Launch HIZENTRA ® in CIDP • Novel delivery devices • New indications e.g. IIM, SSc • rFc multimer | Driven by Our Promise ™ 55 | Driven by Our Promise ™ 55 Proven efficacy and t market new and existing products; difficulties or delays in manufacturing; trade buying patterns and fluctuations in interest and currency exchange rates; legislation or regulations that affect product production, distribution, pr
Text Inhalt Text aus URL
Log Metriken 446174
www.cslbehring.ch
Datum der Indexierung 05.05.2021 18:02:51
erkannte Namen Alex Gertsch | Gérard Jenni | Amir Abrashi | Georg Ptak | Jérôme Gremaud | Bill Mezzanotte | Gene Therapy | Nat Rev | Tim Frei | Lia Huwiler |
weitere Namen in www.cslbehring.ch 11
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf?la=fr-fr&hash=CCC8CC2431742C1F5F685C70278D35BF364E4248
Kombination Keywords promise research | driven therapy | with fluad | cidp cell | phase japan | anti data | transplant market | hizentra study | privigen products | clinical patients |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
build market leading segments • Build on PRIVIGEN® experience in CIDP • Launch HIZENTRA® in CIDP • Novel delivery devices • New indications e.g. IIM, SSc • rFc multimer | Driven by Our Promise™55 | Driven by Our Promise™55 Proven efficacy and tolerab market new and existing products; difficulties or delays in manufacturing; trade buying patterns and fluctuations in interest and currency exchange rates; legislation or regulations that affect product production, distribution, pr
Text Inhalt Text aus URL
Log Metriken 446174
erkannte Namen Alex Gertsch | Gérard Jenni | Amir Abrashi | Georg Ptak | Jérôme Gremaud | Bill Mezzanotte | Gene Therapy | Nat Rev | Tim Frei | Lia Huwiler |
weitere Namen in www.cslbehring.ch 11
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf?la=fr-fr&hash=CCC8CC2431742C1F5F685C70278D35BF364E4248
Kombination Keywords promise research | driven therapy | with fluad | cidp cell | phase japan | anti data | transplant market | hizentra study | privigen products | clinical patients |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
build market leading segments • Build on PRIVIGEN® experience in CIDP • Launch HIZENTRA® in CIDP • Novel delivery devices • New indications e.g. IIM, SSc • rFc multimer | Driven by Our Promise™55 | Driven by Our Promise™55 Proven efficacy and tolerab market new and existing products; difficulties or delays in manufacturing; trade buying patterns and fluctuations in interest and currency exchange rates; legislation or regulations that affect product production, distribution, pr
Text Inhalt Text aus URL
Log Metriken 446174
www.cslbehring.ch
Datum der Indexierung 05.05.2021 04:36:59
erkannte Namen Gérard Jenni | Alex Gertsch | Georg Ptak | Bill Mezzanotte | Jérôme Gremaud | Burkhard Statutory | Corona Anderer |
weitere Namen in www.cslbehring.ch 7
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf?la=fr-fr&hash=494FDD9185B1042615BEEBFB38FFDCB1D72C821B
Kombination Keywords phase privigen | with market | transplant clinical | anti study | cidp research | products hizentra | breakthrough global | medicines development | patients immunoglobulins | haemophilia specialty |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
build market leading segments • Build on PRIVIGEN® experience in CIDP • Launch HIZENTRA® in CIDP • Novel delivery devices • New indications eg IIM, SSc • rFc multimer HIZENTRA®: Innovator, Market Leader 7 years and 51 countries 90,000 patient-years, market new and existing products; difficulties or delays in manufacturing; trade buying patterns and fluctuations in interest and currency exchange rates; legislation or regulations that affect product production, distribution, pr
Text Inhalt Text aus URL
Log Metriken 446193
erkannte Namen Gérard Jenni | Alex Gertsch | Georg Ptak | Bill Mezzanotte | Jérôme Gremaud | Burkhard Statutory | Corona Anderer |
weitere Namen in www.cslbehring.ch 7
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf?la=fr-fr&hash=494FDD9185B1042615BEEBFB38FFDCB1D72C821B
Kombination Keywords phase privigen | with market | transplant clinical | anti study | cidp research | products hizentra | breakthrough global | medicines development | patients immunoglobulins | haemophilia specialty |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
build market leading segments • Build on PRIVIGEN® experience in CIDP • Launch HIZENTRA® in CIDP • Novel delivery devices • New indications eg IIM, SSc • rFc multimer HIZENTRA®: Innovator, Market Leader 7 years and 51 countries 90,000 patient-years, market new and existing products; difficulties or delays in manufacturing; trade buying patterns and fluctuations in interest and currency exchange rates; legislation or regulations that affect product production, distribution, pr
Text Inhalt Text aus URL
Log Metriken 446193
www.cslbehring.ch
Datum der Indexierung 05.05.2021 07:42:21
erkannte Namen Gérard Jenni | Alex Gertsch | Georg Ptak | Bill Mezzanotte | Jérôme Gremaud | Burkhard Statutory | Corona Anderer |
weitere Namen in www.cslbehring.ch 7
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf
Kombination Keywords phase privigen | with market | transplant clinical | anti study | cidp research | products hizentra | breakthrough global | medicines development | patients immunoglobulins | haemophilia specialty |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
build market leading segments • Build on PRIVIGEN® experience in CIDP • Launch HIZENTRA® in CIDP • Novel delivery devices • New indications eg IIM, SSc • rFc multimer HIZENTRA®: Innovator, Market Leader 7 years and 51 countries 90,000 patient-years, market new and existing products; difficulties or delays in manufacturing; trade buying patterns and fluctuations in interest and currency exchange rates; legislation or regulations that affect product production, distribution, pr
Text Inhalt Text aus URL
Log Metriken 469967
erkannte Namen Gérard Jenni | Alex Gertsch | Georg Ptak | Bill Mezzanotte | Jérôme Gremaud | Burkhard Statutory | Corona Anderer |
weitere Namen in www.cslbehring.ch 7
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf
Kombination Keywords phase privigen | with market | transplant clinical | anti study | cidp research | products hizentra | breakthrough global | medicines development | patients immunoglobulins | haemophilia specialty |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
build market leading segments • Build on PRIVIGEN® experience in CIDP • Launch HIZENTRA® in CIDP • Novel delivery devices • New indications eg IIM, SSc • rFc multimer HIZENTRA®: Innovator, Market Leader 7 years and 51 countries 90,000 patient-years, market new and existing products; difficulties or delays in manufacturing; trade buying patterns and fluctuations in interest and currency exchange rates; legislation or regulations that affect product production, distribution, pr
Text Inhalt Text aus URL
Log Metriken 469967